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licenseInteraction between proteineenergy wasting and geriatric
nutritional risk index in elderly patients on dialysisProteineenergy malnutrition has been proposed to be a
cause of refractory anemia that accompanies the malnu-
tritioneinflammation complex (or cachexia) syndrome in
dialysis patients.1 Malnutritioneinflammation complex syn-
drome and the obesity paradox are also the main etiology for
“reverse epidemiology” of cardiovascular risk factors and
outcomes in dialysis patients.1,2 However, in some dialysis
patients, protein-energy wasting (PEW) is not related to
inadequate nutrient intake.3 The 2013 International Society of
Renal Nutrition and Metabolism meeting report notes that
PEW is responsible for loss of protein mass and fuel reserve,
and that PEW is a nonspecific inflammatory process. The term
kidney disease wasting emphasizes the strong association
between kidney diseases and PEW.3 However, kidney disease
wasting does not provide any insight into the different causes
of PEW in kidney disease. Moreover, the lack of association
between kidney disease (acute kidney injury and chronic
kidney disease) and PEW may be found between young
(pancreatitis) and elderly individuals (chronic obstructive
pulmonary disease) with different etiologies. Therefore, the
expert panel reached the conclusion that the term kidney
disease wasting is not a suitable substitute for PEW.
There is a wide variety of causes of PEWand frailty in elderly
patients with end-stage renal disease, including genotype, phe-
notype, comorbid conditions, duration and severity of renal
failure, psychosocial problems, and lifestyle, in addition to low
anabolic (insulin, growth hormone, and insulin growth factor-1)
but high catabolic hormones (parathyroid hormone and gluca-
gon), and age-related mitochondrial dysfunction and oxidative
stress.3e6 Numerous different terminologies have been used to
describe the phenomena of malnutrition and inflammatory
wasting coexisting in patients with kidney diseases, such as
uremic malnutrition, proteineenergy malnutrition, malnu-
tritioneinflammation atherosclerosis syndrome, and malnu-
tritioneinflammation complex syndrome. Several inflammatory
markers, such as C-reactive protein, interleukin-6, tumor
necrosis factor-a, interleukin-1, and serum amyloid A, have
recently been shown to be associated with concomitant malnu-
trition and inflammatory wasting.6
Geriatric Nutritional Risk Index (GNRI) was first used to
evaluate malnutrition and related morbidity and mortality inx.doi.org/10.1016/j.jcma.2016.01.004
901/Copyright © 2016, the Chinese Medical Association. Published by El
(http://creativecommons.org/licenses/by-nc-nd/4.0/).elderly patients.7 It was validated to be a simple and objective
screening tool requiring serum albumin, adjusted for ideal
body weight and knee height. Recent studies applied GNRI to
predict outcomes of heart failure and PEW in maintenance
hemodialysis patients.8,9 A wide variety of other instruments
have been used for nutritional evaluation, such as the Sub-
jective Global Assessment, Mini Nutritional Assessment-
Screening Form, Malnutrition Universal Screening Tool, and
Nutritional Risk Screening 2002.8 Physical performance is
also an important predictor of outcomes in the elderly and frail
people. Chronic kidney disease and end-stage renal disease
facilitate the process of wasting before the onset of frank
cachexia. The Comprehensive Dialysis Study of the United
States Renal Data System investigated the frailty, dialysis
initiation, and mortality in maintenance dialysis.10 However,
the questionnaires, including the Research ANd Development
(RAND) 12-item Short Form, 36-item Kidney Disease Quality
of Life symptom scale, and Human Activity Profile via tele-
phone interviews were subjective.10
Tsai et al11 applied GNRI and demonstrated its long-term
predictive value in a prospective cohort of elderly patients
who underwent chronic hemodialysis. The authors concluded
that patients with a GNRI of < 92 at baseline had significantly
increased all-cause mortality during long-term follow-up. In
addition, a low body mass index but high erythropoietin
resistance index and high-sensitivity C-reactive protein were
correlated with a low GNRI. Those patients with a low GNRI
also had a low body weight, low body mass index, low serum
albumin, low hemoglobin, and high erythropoietin resistance
index initially. These variables are compatible with the
symptoms of PEW.
This study had some limitations. First, this was a single-
dialysis-unit study and thus could not represent the out-
comes of all patients in our nationwide cohort. Second,
although GNRI consists of simple objective measurements, the
calculated parameter of weight/WLo (Lorentz equations)
should be adjusted according to different values for GNRI,
albumin, and weight loss.7 It could not be clearly determine
whether any modification of the equation through the detailed
description was necessary. Third, erythropoietin resistance
index is defined as the erythropoietin dose administered persevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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has been suggested that the average value be monitored over a
3-month period to determine whether there is any possibility
of correctable blood loss or illness.1 Moreover, the eryth-
ropoietin responsiveness index with the same calculation was
also used.
The quality of dialysis has greatly improved in Taiwan. We
observed the same and improved patterns and percentages of
cumulative survival between elderly dialysis patients with a
GNRI of  92 and those with pure frailty without dialysis.10,11
However, the mean age of the pure frailty group was com-
paratively higher.10 Dialysis may reverse uremia, but residual
metabolic derangements, inflammation, comorbid conditions,
and the dialysis procedure itself may allow PEW to develop or
worsen. Furthermore, it is possible that weight gain may occur
while losing muscle, a phenomenon known as sarcopenic
obesity, which is an important issue that needs to be
addressed.12,13 The time-averaged serum creatinine concen-
tration is a more appropriate surrogate of muscle mass, and
changes of serum creatinine over time may represent parallel
changes in skeletal muscle mass.13 Nutritional recom-
mendations for the management of sarcopenic obesity are
similar to those for PEW, which include exercise (aerobic and
resistance), anti-inflammatory strategies, and adequate protein
intake.6,14
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